Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-analysis of clinically diagnosed LOAD (94,437 individuals). We confirm 20 previous LOAD risk loci and identify five new genome-wide loci (IQCK, ACE, ADAM10, ADAMTS1, and WWOX), two of which (ADAM10, ACE) were identified in a recent genome-wide association (GWAS)-by-familial-proxy of Alzheimer’s or dementia. Fine-mapping of the human leukocyte antigen (HLA) region confirms the neurological and immune-mediated disease haplotype HLA-DR15 as a risk factor for LOAD. Pathway analysis implicates immunity, lipid metabolism, tau binding proteins, and amyloid precursor protein (APP) metabolism, showing that genetic variants affecting APP and Aβ processing are associated not only with early-onset autosomal dominant Alzheimer’s disease but also with LOAD. Analyses of risk genes and pathways show enrichment for rare variants (P = 1.32 × 10−7), indicating that additional rare variants remain to be identified. We also identify important genetic correlations between LOAD and traits such as family history of dementia and education.

Genetic | Nick C Fox | Michelle K. Lupton | Charles C. White | C. Carlson | J. Gallacher | M. Fornage | K. Lunetta | A. Singleton | D. Geschwind | I. Giegling | A. Hartmann | M. Nöthen | D. Grozeva | M. Gill | M. Owen | H. Hakonarson | J. Buxbaum | M. Cuccaro | M. Pericak-Vance | G. Schellenberg | E. Boerwinkle | M. Albert | C. DeCarli | R. Green | P. Holmans | R. Gwilliam | C. Lyketsos | D. Bennett | V. Gudnason | A. Myers | R. Lipton | T. Montine | M. Mesulam | R. Petersen | J. Trojanowski | F. Jessen | D. Blacker | J. Growdon | B. Hyman | B. Reisberg | A. Saykin | W. Maier | J. Becker | B. Dubois | R. Albin | D. Mash | A. Levey | M. Mayhaus | C. Caltagirone | G. Spalletta | W. Bush | Qiong Yang | F. Rivadeneira | J. Kaye | I. Heuser | L. Fratiglioni | R. Mayeux | M. Sano | B. Boeve | H. Paulson | H. Wichmann | O. Lopez | P. Deloukas | L. Apostolova | M. Rossor | H. Soininen | D. Galasko | F. Pasquier | E. Masliah | M. Frosch | G. Livingston | D. Dickson | J. Parisi | R. Doody | J. Quinn | J. Dartigues | N. Cairns | B. Ghetti | J. Ringman | E. Reiman | E. Martin | J. Vance | A. McQuillin | N. Bass | L. Honig | J. Schott | H. Hampel | D. Royall | S. Arnold | L. Farrer | J. Rotter | N. Klopp | P. Mecocci | B. Vellas | M. Tsolaki | I. Kloszewska | S. Lovestone | H. Chui | K. Sleegers | C. van Broeckhoven | S. Engelborghs | C. Brayne | J. Kramer | W. Seeley | K. Welsh-Bohmer | E. Bigio | S. Weintraub | R. Tanzi | R. Vandenberghe | M. Gearing | D. Harold | P. Hollingworth | R. Sims | A. Gerrish | J. Powell | D. Rubinsztein | B. Lawlor | A. Lynch | K. Morgan | K. Brown | P. Passmore | D. Craig | B. McGuinness | C. Holmes | D. Mann | A. Smith | S. Love | P. Kehoe | S. Mead | J. Collinge | J. Kornhuber | J. Wiltfang | M. Dichgans | M. Hüll | A. Goate | K. Mayo | A. Al-Chalabi | C. Shaw | R. Guerreiro | S. Moebus | K. Jöckel | M. Carrasquillo | S. Younkin | Julie Williams | J. Lambert | Carlos Cruchaga | H. Vinters | Denis A. Evans | P. D. De Jager | L. Cupples | W. Kukull | H. Rosen | C. Dufouil | S. Sorbi | T. Foroud | P. Crane | D. Beekly | L. Harrell | J. Troncoso | C. Reitz | H. Schmidt | H. van den Bussche | L. Frölich | J. Kauwe | Á. Carracedo | D. Campion | M. Hiltunen | M. Bullido | C. Berr | N. Fievet | I. Mateo | S. Helisalmi | O. Hanon | V. Álvarez | M. Mancuso | F. Panza | B. Nacmias | P. Bossù | D. Galimberti | D. Hannequin | K. Ritchie | A. Beiser | A. Boxer | A. Karydas | N. Hooper | A. Koivisto | D. Marson | K. Wilhelmsen | J. Bis | M. Huentelman | J. Lah | X. Jian | E. Scarpini | J. Reisch | A. Brice | U. Bonuccelli | N. Amin | G. Eiriksdottir | M. Garcia | L. Launer | T. Aspelund | M. Riemenschneider | J. Warren | L. Lannfelt | A. McDavid | T. Bird | D. Warden | C. Medway | Shubhabrata Mukherjee | D. Fardo | A. Naj | C. Bellenguez | G. Jun | G. Beecham | B. Grenier‐Boley | G. Russo | V. Chouraki | B. Vardarajan | B. Kunkle | A. Ruiz | S. Choi | A. Ramírez | A. Fitzpatrick | C. Baldwin | V. Deramecourt | J. Johnston | M. Kamboh | L. Keller | E. Larson | D. Wallon | E. Rogaeva | P. George-Hyslop | J. Clarimón | A. Lleó | A. Bayer | D. Tsuang | M. Naranjo | R. Clarke | A. Pilotto | P. Caffarra | M. Ingelsson | O. Valladares | E. Coto | K. Hamilton-Nelson | W. Gu | P. Pástor | K. Faber | L. Cantwell | T. Mosley | M. Boada | Li-San Wang | C. Graff | L. Jones | S. Seshadri | T. Beach | Chang-En Yu | G. Jarvik | Y. Ben-Shlomo | J. Vonsattel | R. Rosenberg | H. Kölsch | S. Riedel-Heller | N. Graff-Radford | S. Asthana | C. Carlsson | M. Sager | R. Stern | G. Wilcock | O. Peters | S. O'Bryant | L. Concari | M. Allen | Li Ma | G. Bisceglio | A. Daniele | R. Swerdlow | M. Farlow | N. Kowall | D. Bacq | C. Hulette | V. Solfrizzi | R. Woltjer | E. Roberson | S. Ferris | W. Longstreth | F. LaFerla | C. Cupidi | E. Peskind | J. Bras | R. Munger | C. Corcoran | J. Tschanz | S. Debette | J. Bowen | W. McCormick | S. McCurry | V. Giedraitis | P. Hoffmann | A. Hodges | J. Olichney | R. Heun | J. Burke | P. Whitehead | V. Escott-Price | E. Abner | C. Keene | Cohorts for Heart | Environmental Risk in Ad | Polygenic Defining Genetic | Perades | T. Wingo | L. Barnes | L. Tárraga | A. Boland | J. Deleuze | S. Barral | Mariusz Butkiewicz | R. Duara | E. Crocco | E. Hofer | C. Atwood | N. Badarinarayan | D. Drichel | A. Bruni | S. Pickering-Brown | I. Hernández | J. Burns | D. Cribbs | P. Sánchez-Juan | P. Proitsi | N. Ryan | C. Wright | M. Scherer | S. Moreno-Grau | I. de Rojas | M. Raskind | A. Lieberman | I. Álvarez | M. Diez-Fairen | M. Gallo | R. Maletta | V. V. Van Deerlin | I. Quintela | J. Jakobsdóttir | R. Kim | J. Leverenz | L. V. Van Eldik | E. Fisher | S. Sordon | S. J. van der Lee | M. Vronskaya | M. Ikram | N. Denning | R. Barber | L. Qu | Yuning Chen | C. Sarnowski | W. Perry | Amanda G. Smith | M. Katz | V. Frisardi | R. Hamilton | C. Cao | R. Carney | M. Dick | K. Fallon | F. Martiniuk | C. Miller | Joshua W. Miller | A. Pierce | W. Poon | H. Potter | A. Raj | J. Sonnen | S. Spina | J. Williamson | R. Olaso | L. Real | J. Epelbaum | S. Slifer | G. Menzies | B. Dombroski | E. Vardy | T. Feulner | L. Kilander | R. Raybould | M. Leber | M. Daniilidou | O. Gkatzima | E. Rodríguez-Rodríguez | J. Turton | R. Sussams | A. Squassina | T. Morgan | Yi Zhao | J. Malamon | V. Boccardi | C. Masullo | T. Fairchild | E. Sacchinelli | R. Huebinger | Shuo Li | A. Meggy | R. Marshall | J. Uphill | Y. Patel | J. T. Hughes | J. Lord | R. Cecchetti | M. D. Orfei | A. Ciaramella | F. Garzia | Y. A. Benito | H. Thonberg | R. Brundin | A. Haapasalo | Y. Saba | V. Damotte | G. Nicolas | A. Amlie-Wolf | A. Frizatti | Jean-Guillaume Garnier | Marie-Laure Moutet | M. Del Zompo | B. Fin | S. Meslage | D. Voijnovic | A. Orellana | Carmen Munoz-Fernadez | Hata Karamujić‐Čomić | G. Roschupkin | A. Kawalia | F. Salani | A. G. Andre Uitterlinden | D. Avramidou | A. Germanou | M. Koutroumani | G. Leonenko | L. S. Schneider | Mitchell Tang | P. Bosco | N. Warner | N. Ertekin-Taner | P. Amouyel | Jennifer A. Brody | J. Himali | Lee‐way Jin | P. D. de Deyn | S. Ahmad | F. Sánchez‐garcía | T. Cushion | J. Schneider | Chuang‐Kuo Wu | Yuenjoo Song | Michael C. O’Donovan | Lei Yu | A. Smith | A. Mckee | P. Adams | J. Gilbert | B. Miller | C. V. van Duijn | B. Psaty | A. Kuzma | Honghuang Lin | A. Destefano | J. Hardy | J. Haines | H. Adams | R. Schmidt | J. Morris

[1]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[2]  M. Owen,et al.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.

[3]  E. Masliah,et al.  C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders , 2000, Acta Neuropathologica.

[4]  E. Rogaev,et al.  Association between angiotensin-converting enzyme and Alzheimer disease. , 2000, Archives of neurology.

[5]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[6]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[7]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[8]  J. Heath,et al.  Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro , 2004, Journal of Biological Chemistry.

[9]  Christopher B. Burge,et al.  Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals , 2004, J. Comput. Biol..

[10]  E. Godaux,et al.  A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. , 2004, The Journal of clinical investigation.

[11]  G. Lubec,et al.  Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease. , 2005, Brain Research. Molecular Brain Research.

[12]  K. Sleegers,et al.  Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. , 2005, American journal of epidemiology.

[13]  The Protooncogene c-Maf Is an Essential Transcription Factor for IL-10 Gene Expression in Macrophages1 , 2005, The Journal of Immunology.

[14]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[15]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[16]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[17]  Rivka Inzelberg,et al.  Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. , 2006, American journal of human genetics.

[18]  D. Williamson,et al.  HLA-DR15 haplotype and multiple sclerosis: a HuGE review. , 2007, American journal of epidemiology.

[19]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[20]  B. Su,et al.  MEKK3 is essential for lipopolysaccharide‐induced interleukin‐6 and granulocyte–macrophage colony‐stimulating factor production in macrophages , 2007, Immunology.

[21]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[22]  J. Ting,et al.  The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. , 2008, Molecular Immunology.

[23]  Sudha Seshadri,et al.  Thyroid function and the risk of Alzheimer disease: the Framingham Study. , 2008, Archives of internal medicine.

[24]  T. Lehtimäki,et al.  WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. , 2008, American Journal of Human Genetics.

[25]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[26]  Adam Byron,et al.  Proteomic Analysis of Integrin-Associated Complexes Identifies RCC2 as a Dual Regulator of Rac1 and Arf6 , 2009, Science Signaling.

[27]  S. Akira,et al.  Two Mechanistically and Temporally Distinct NF-κB Activation Pathways in IL-1 Signaling , 2009, Science Signaling.

[28]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[29]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[30]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[31]  S. Love,et al.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. , 2009, American journal of translational research.

[32]  Yaakov Stern,et al.  Contribution of vascular risk factors to the progression in Alzheimer disease. , 2009, Archives of neurology.

[33]  K. Elliott,et al.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. , 2009, Human molecular genetics.

[34]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[35]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[36]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[37]  Q. Hu,et al.  A Flanking Gene Problem Leads to the Discovery of a Gprc5b Splice Variant Predominantly Expressed in C57Bl/6J Mouse Brain and in Maturing Neurons , 2010, PLoS ONE.

[38]  K. Lunetta,et al.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.

[39]  Henrik,et al.  Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index , 2012 .

[40]  R. Mayeux,et al.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. , 2010, Archives of neurology.

[41]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[42]  Ming-Huei Chen,et al.  GWAF: an R package for genome-wide association analyses with family data , 2010, Bioinform..

[43]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[44]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[45]  M. Martínez-Larrad,et al.  WWOX gene is associated with HDL cholesterol and triglyceride levels , 2010, BMC Medical Genetics.

[46]  Hongyu Zhao,et al.  A Genome-Wide Association Study on Obesity and Obesity-Related Traits , 2011, PloS one.

[47]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[48]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[49]  M. Owen,et al.  A multi-center study of ACE and the risk of late-onset Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[50]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[51]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[52]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[53]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy , 2011, Nucleic Acids Res..

[54]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[55]  P. Venkatraman,et al.  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO. , 2012, Immunology letters.

[56]  Y. Stern Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[57]  J. Buxbaum,et al.  Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer Disease , 2012, Neurobiology of Aging.

[58]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[59]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[60]  C. Haass,et al.  Trafficking and proteolytic processing of APP. , 2012, Cold Spring Harbor perspectives in medicine.

[61]  F. Pasquier,et al.  Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites , 2011, Molecular Psychiatry.

[62]  Y. Hirabayashi,et al.  GPRC5B Activates Obesity-Associated Inflammatory Signaling in Adipocytes , 2012, Science Signaling.

[63]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[64]  L. Stefanis α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[65]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[66]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[67]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[68]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[69]  D. Wilcock Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease , 2012, Current gerontology and geriatrics research.

[70]  Michael Boehnke,et al.  Recommended Joint and Meta‐Analysis Strategies for Case‐Control Association Testing of Single Low‐Count Variants , 2013, Genetic epidemiology.

[71]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[72]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[73]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[74]  Carol Moreno,et al.  Identifying multiple causative genes at a single GWAS locus , 2013, Genome research.

[75]  B. Nsiri,et al.  Association of HLA-DR-DQ polymorphisms with diabetes in Tunisian patients. , 2013, Transfusion and Apheresis Science.

[76]  M. Owen,et al.  Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.

[77]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[78]  R. Vassar,et al.  ADAM10 Prodomain Mutations Cause Late-Onset Alzheimer’s Disease: Not Just the Latest FAD , 2013, Neuron.

[79]  W. M. van der Flier,et al.  The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.

[80]  S. Factor,et al.  Association of Parkinson disease with structural and regulatory variants in the HLA region. , 2013, American journal of human genetics.

[81]  Andrew D. Johnson,et al.  Synthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs , 2014, BMC Genomics.

[82]  R. Tanzi,et al.  ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.

[83]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[84]  D. Fardo,et al.  ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status , 2013, Neuroscience Letters.

[85]  M. Nguyen,et al.  The G protein-coupled receptor GPRC5B contributes to neurogenesis in the developing mouse neocortex , 2013, Development.

[86]  M. Carrington,et al.  Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects , 2013, PLoS genetics.

[87]  Xue-bin Wang,et al.  Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis , 2014, PLoS ONE.

[88]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[89]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[90]  H. Mansvelder,et al.  Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease , 2014, Acta neuropathologica communications.

[91]  B S Weir,et al.  HIBAG—HLA genotype imputation with attribute bagging , 2013, The Pharmacogenomics Journal.

[92]  Fuhai Song,et al.  AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[93]  C. Gieger,et al.  Mapping the Genetic Architecture of Gene Regulation in Whole Blood , 2014, PloS one.

[94]  C. Sze,et al.  WW domain-containing oxidoreductase in neuronal injury and neurological diseases , 2014, OncoTarget.

[95]  P. Matthews,et al.  A common brain network links development, aging, and vulnerability to disease , 2014, Proceedings of the National Academy of Sciences.

[96]  C. Jack,et al.  Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias , 2014, Alzheimer's Research & Therapy.

[97]  I. Heid,et al.  Genetic variation at the CELF1 (CUGBP, elav‐like family member 1 gene) locus is genome‐wide associated with Alzheimer's disease and obesity , 2014, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[98]  N. Perrimon,et al.  Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms. , 2014, Human molecular genetics.

[99]  J. Dorszewska,et al.  [Alpha-synuclein in Parkinson's disease]. , 2014, Przeglad lekarski.

[100]  L. Vargova,et al.  ECM in brain aging and dementia. , 2014, Progress in brain research.

[101]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[102]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[103]  Perry G. Ridge,et al.  Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation , 2014, PLoS genetics.

[104]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[105]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[106]  A. Suttkus,et al.  Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress , 2014, Cell Death and Disease.

[107]  H. Stefánsson,et al.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease , 2015, Circulation.

[108]  N. Greig,et al.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. , 2015, Current Alzheimer research.

[109]  C. Morrison,et al.  Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis , 2015, PLoS medicine.

[110]  Yufeng Shen,et al.  Coding mutations in SORL1 and Alzheimer disease , 2015, Annals of neurology.

[111]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[112]  H. Stefánsson,et al.  Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease , 2015, Nature Genetics.

[113]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[114]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[115]  P. Flicek,et al.  The Ensembl Regulatory Build , 2015, Genome Biology.

[116]  S. Rivest,et al.  The dynamics of monocytes and microglia in Alzheimer’s disease , 2015, Alzheimer's Research & Therapy.

[117]  Adult Changes in Thought Study Investigators,et al.  Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses , 2015 .

[118]  Janos X. Binder,et al.  DISEASES: Text mining and data integration of disease–gene associations , 2014, bioRxiv.

[119]  Kevin L. Boehme,et al.  Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study , 2015, PLoS medicine.

[120]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[121]  C. DeCarli,et al.  Are low levels of PiB-PET signal clinically significant? , 2015, Alzheimer's & Dementia.

[122]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[123]  J. Schneider,et al.  Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance , 2015, Nature Neuroscience.

[124]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[125]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[126]  Christian Stolte,et al.  Comprehensive comparison of large-scale tissue expression datasets , 2015, bioRxiv.

[127]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[128]  Carsten O. Daub,et al.  Transcriptional Dynamics Reveal Critical Roles for Non-coding RNAs in the Immediate-Early Response , 2015, PLoS Comput. Biol..

[129]  Gabi Kastenmüller,et al.  SNiPA: an interactive, genetic variant-centered annotation browser , 2014, Bioinform..

[130]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..

[131]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[132]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[133]  J. Chang,et al.  WWOX dysfunction induces sequential aggregation of TRAPPC6AΔ, TIAF1, tau and amyloid β, and causes apoptosis , 2015, Cell Death Discovery.

[134]  Clifford R. Jack,et al.  Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum , 2015, Brain : a journal of neurology.

[135]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[136]  Henrik Zetterberg,et al.  Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism , 2016, Acta Neuropathologica.

[137]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[138]  R. Gross Spotlight on the January 5 Issue , 2016, Neurology.

[139]  R. Redon,et al.  ABCA7 rare variants and Alzheimer disease risk , 2016, Neurology.

[140]  Yi Su,et al.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease , 2016, Science Translational Medicine.

[141]  L. Dimeglio,et al.  HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression , 2016, Diabetes.

[142]  Kevin L. Boehme,et al.  Assessment of the genetic variance of late-onset Alzheimer's disease , 2016, Neurobiology of Aging.

[143]  Rebecca C. Knickmeyer,et al.  Imaging and rare APOE alleles , 2016, Neurology.

[144]  J. Buxbaum,et al.  A SPECTRAL APPROACH INTEGRATING FUNCTIONAL GENOMIC ANNOTATIONS FOR CODING AND NONCODING VARIANTS , 2015, Nature Genetics.

[145]  D. Campion,et al.  Alzheimer disease: modeling an Aβ-centered biological network , 2016, Molecular Psychiatry.

[146]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[147]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[148]  Giuliano Binetti,et al.  A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease , 2016, Acta Neuropathologica.

[149]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[150]  Henning Hermjakob,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic acids research.

[151]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[152]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[153]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[154]  Yara T. E. Lechanteur,et al.  Nature Genetics Advance Online Publication , 2022 .

[155]  S. Park,et al.  Diaminodiphenyl sulfone–induced parkin ameliorates age-dependent dopaminergic neuronal loss , 2016, Neurobiology of Aging.

[156]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[157]  Kevin L. Boehme,et al.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case–control study , 2017, PLoS medicine.

[158]  M. Glymour,et al.  Contribution of Socioeconomic Status at 3 Life-Course Periods to Late-Life Memory Function and Decline: Early and Late Predictors of Dementia Risk , 2017, American journal of epidemiology.

[159]  Robert M. Maier,et al.  Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, Nature Communications.

[160]  S. Larsson,et al.  Genetically-Predicted Adult Height and Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[161]  H. Soininen,et al.  Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.

[162]  Eugenia G. Giannopoulou,et al.  Interferon‐&ggr; Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF , 2017, Immunity.

[163]  Tom R. Gaunt,et al.  LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.

[164]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[165]  J. Gilbert,et al.  Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease , 2017, Neuroscience Letters.

[166]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[167]  Yaniv Erlich,et al.  Case–control association mapping by proxy using family history of disease , 2017, Nature Genetics.

[168]  M. Tsolaki,et al.  Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease , 2017, Acta Neuropathologica.

[169]  A. Fagan,et al.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.

[170]  M. Daly,et al.  Regional missense constraint improves variant deleteriousness prediction , 2017, bioRxiv.

[171]  R. Redon,et al.  Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls , 2017, Neurobiology of Aging.

[172]  N. Chang,et al.  Zfra restores memory deficits in Alzheimer's disease triple-transgenic mice by blocking aggregation of TRAPPC6AΔ, SH3GLB2, tau, and amyloid β, and inflammatory NF-κB activation , 2017, Alzheimer's & dementia.

[173]  K. Hao,et al.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease , 2017, Nature Neuroscience.

[174]  Catherine A. Macleod,et al.  Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study , 2017, PLoS medicine.

[175]  C. Sudlow,et al.  Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population , 2017, American journal of epidemiology.

[176]  William T. Hu,et al.  Poly(Gp) Proteins Are A Useful Pharmacodynamic Marker For C9Orf72-Associated Amyotrophic Lateral Sclerosis , 2017 .

[177]  K. Lunetta,et al.  Transethnic genome-wide scan identifies novel Alzheimer's disease loci , 2017, Alzheimer's & Dementia.

[178]  Lisa Bastarache,et al.  Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants , 2017, Science Translational Medicine.

[179]  J. Hollenbach,et al.  The immunogenetics of neurological disease , 2018, Immunology.

[180]  Christopher D. Brown,et al.  INFERNO: inferring the molecular mechanisms of noncoding genetic variants , 2018, Nucleic acids research.

[181]  K. Sleegers,et al.  An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease , 2018, Acta Neuropathologica.

[182]  D. Llewellyn,et al.  Individual and Area-Based Socioeconomic Factors Associated With Dementia Incidence in England , 2018, JAMA psychiatry.

[183]  P. May,et al.  Rare ABCA7 variants in 2 German families with Alzheimer disease , 2018, Neurology: Genetics.

[184]  Calliope A. Dendrou,et al.  HLA variation and disease , 2018, Nature Reviews Immunology.

[185]  Charles C. White,et al.  A transcriptomic atlas of aged human microglia , 2018, Nature Communications.

[186]  Nick C Fox,et al.  The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial. , 2017, Journal of Alzheimer's disease : JAD.

[187]  Sina A. Gharib,et al.  Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.

[188]  D. Bennett,et al.  Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology , 2018, Neurology.

[189]  Kathleen M Jagodnik,et al.  Massive mining of publicly available RNA-seq data from human and mouse , 2017, Nature Communications.

[190]  D. Llewellyn,et al.  Which Risk Factors Causally Influence Dementia? A Systematic Review of Mendelian Randomization Studies , 2018, Journal of Alzheimer's disease : JAD.

[191]  Shijie Zhang,et al.  GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits , 2018, Nucleic Acids Res..

[192]  P. Kehoe The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment? , 2018, Journal of Alzheimer's disease : JAD.

[193]  R. Marioni,et al.  GWAS on family history of Alzheimer’s disease , 2018, bioRxiv.

[194]  M. Fornage,et al.  Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation , 2018, Molecular Psychiatry.